August 5, 2015

Kite Pharma to Present at the Canaccord Genuity 35th Annual Growth Conference

August 4, 2015

Capricor Therapeutics Appoints Deborah Ascheim, M.D. as Chief Medical Officer

July 1, 2015

Kite Pharma and The Leukemia & Lymphoma Society(R) Enter Into Collaboration to Enhance the Development of KTE-C19 in Refractory Aggressive Non-Hodgkin Lymphoma and Launch CAR T-Cell Therapy Educational Programs

June 22, 2015

Capricor Therapeutics, Inc. (Nasdaq: CAPR) to Ring The Nasdaq Stock Market Closing Bell

June 22, 2015

Kite Pharma and bluebird bio Announce Strategic Collaboration to Advance Second Generation TCR Cell Therapy Products to Treat HPV-Associated Cancers

June 19, 2015

Capricor Therapeutics and CureDuchenne to Host Webinar on June 19, 2015 at 3:00 p.m. ET

June 17, 2015

Capricor Therapeutics Appoints Houman Hemmati M.D., Ph.D. to Vice President of Medical and Clinical Development for New Therapies

June 16, 2015

Kite Pharma to Host Investor Day on June 23, 2015

June 8, 2015

Capricor Announces Receipt of FDA Clearance for the Phase I/II Study of CAP-1002 for the Treatment of Duchenne Muscular Dystrophy Related Cardiomyopathy

June 4, 2015

Arno Therapeutics Announces Issuance of First Onapristone Patent

June 3, 2015

Arno Therapeutics Announces Cooperative Research and Development

June 2, 2015

Kite Pharma Presents Clinical Biomarker Results in Patients Treated With Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy at the 2015 ASCO Annual Meeting

May 29, 2015

Kite Pharma to Present Clinical Biomarkers From Patients Treated With Anti-CD19 Chimeric Antigen Receptor T Cell Therapy at the 2015 ASCO Annual Meeting

May 28, 2015

Arno Therapeutics Announces AR-12 Antiviral Data Against Multiple Hemorrhagic Fevers Published Online in Antiviral Research

May 26, 2015

Kite Pharma to Present at the Jefferies 2015 Global Healthcare Conference

May 26, 2015

Capricor Therapeutics to Participate in Two Upcoming Investor Conferences in June

May 12, 2015

Capricor Therapeutics Reports First Quarter 2015 Financial & Business Highlights

May 12, 2015

Kite Pharma to Report First Quarter Financial Results on Friday, May 15, 2015

May 7, 2015

Arno Therapeutics Receives USPTO Notice of Allowance for Two Important Patents Covering Lead Compound Onapristone

May 5, 2015

Capricor Therapeutics to Hold First Quarter 2015 Business Update and Financial Results Conference Call on May 12, 2015 at 4:30 p.m. EDT

April 30, 2015

Arno Therapeutics Receives European Orphan Drug Designation for AR-12 to Treat Two Infectious Diseases

April 29, 2015

Arno Therapeutics to Present Three Posters Supporting Onapristone Development at ASCO Annual Meeting 2015

April 22, 2015

Capricor Granted FDA Orphan Drug Designation for Allogeneic Cardiosphere-Derived Cells for the Treatment of Duchenne Muscular Dystrophy

April 21, 2015

Kite Pharma Commends Honors Conferred to Drs. Owen Witte and Steven A. Rosenberg at the 2015 American Association for Cancer Research (AACR) Annual Meeting

April 21, 2015

Arno Therapeutics to Present Promising Data from Phase I Trial of Onapristone at AACR Annual Meeting 2015